JPH0147154B2 - - Google Patents

Info

Publication number
JPH0147154B2
JPH0147154B2 JP56120544A JP12054481A JPH0147154B2 JP H0147154 B2 JPH0147154 B2 JP H0147154B2 JP 56120544 A JP56120544 A JP 56120544A JP 12054481 A JP12054481 A JP 12054481A JP H0147154 B2 JPH0147154 B2 JP H0147154B2
Authority
JP
Japan
Prior art keywords
glutathione
gsh
activity
strain
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56120544A
Other languages
Japanese (ja)
Other versions
JPS5820196A (en
Inventor
Hikari Kimura
Kosaku Murata
Joji Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP56120544A priority Critical patent/JPS5820196A/en
Priority to EP82304039A priority patent/EP0071485B1/en
Priority to DE8282304039T priority patent/DE3279950D1/en
Priority to ES514571A priority patent/ES514571A0/en
Priority to CA000408484A priority patent/CA1187432A/en
Publication of JPS5820196A publication Critical patent/JPS5820196A/en
Priority to ES522801A priority patent/ES8500328A1/en
Priority to US06/670,675 priority patent/US4596775A/en
Publication of JPH0147154B2 publication Critical patent/JPH0147154B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 本発明はグルタチオンの製造法に関し、更に詳
しくはグルタチオンの合成酵素系の制御機構が解
除されたエシエリヒア属に属する微生物の菌体よ
り抽出法によつてグルタチオンを製造する方法に
関する。 グルタチオンはL−グルタミン酸、L−システ
イン及びグルシンより成るトリペプチドであり、
肝疾患治療剤、解毒剤などとして有用な物質であ
り、また生化学的試薬としても有用な物質であ
る。 従来、微生物を用いてグルタチオンを製造する
方法としては、酵母菌体よりグルタチオンを抽出
する方法、膜透過性のよい乾燥酵母にL−グルタ
ミン酸、L−システイン及びグリシンを含有する
基質溶液を接触させてグルタチオンを生成させる
方法、酵母や大腸菌の菌体に基質溶液を接触させ
てグルタチオンを生成させるに際しATP再生系
を共役させる方法などが知られている。しかしな
がら、工業的製法としてみた場合、これらの方法
はグルタチオンの生産量が必ずしも満足しうるも
のでなかつた。 本発明者らは、かかる状況に鑑み、微生物を用
いて工業的有利にグルタチオンを製造する方法を
見い出すべく種々研究を重ねた結果、エシエリヒ
ア属に属し、γ−グルタミルシステイン合成酵素
活性及びグルタチオン合成酵素活性を有し、かつ
グルタチオンによるγ−グルタミルシステイン酵
素への阻害が解除された微生物が菌体内に著量の
グルタチオンを蓄積することを見い出し、本発明
を完成するに至つた。 即ち、本発明は上記微生物を培養し、かくして
得られた菌体よりグルタチオンを抽出することか
らなるグルタチオンの製造法である。 本発明で使用する微生物は、エシエリヒア属に
属し、γ−グルタミルシステイン合成酵素(E.
C.6.3.2.2.、以下本酵素をGSH−と称する)活
性及びグルタチオン合成酵素(E.C.6.3.2.3.、以下
本酵素をGSH−と称する)活性を有し、かつ
グルタチオンによるGSH−への阻害が解除さ
れた微生物であればいずれも使用することがで
き、かかる微生物の代表的な例としてはGSH−
活性及びGSH−活性を有し、かつグルタチ
オンによるGSH−への阻害が解除されたエシ
エリヒア・コリが好適に挙げられる。 上記菌株は例えば次の如くして取得することが
できる。まず、GSH−活性及びGSH−活性
を有するエシエリヒア・コリの野性株(例えば、
エシエリヒア・コリB355)に変異を誘起せしめ
てシステイン要求株及びメチルグリオキサール耐
性株を取得する。変異の誘起は通常の変異誘起処
理により行なうことができ、例えばN−メチル−
N′−ニトロ−N−ニトロソグアニジンの如き変
異誘起剤で処理することにより実施することがで
きる。システイン要求株の取得は変異誘起処理し
て得られる菌株をシステイン2×10-5Mを含む最
少培地(例えば、K2HPO40.7%、KH2PO40.3%、
(NH42SO40.1%、グルコース0.5%の組成の培
地、以下DM培地と称する)で培養し、生じた小
コロニーを釣菌分離することにより取得すること
ができる。一方、メチルグリオキサール耐性株は
前記の変異誘起処理して得られる菌株をメチルグ
リオキサールを含むDM培地に培養し、生じた大
きなコロニーを釣菌分離することにより取得する
ことができる。次いで、上記で取得したシステイ
ン要求株を含む最少培地に上記メチルグリオキサ
ール耐性株を培養し、コロニーの周辺にハローを
作らないコロニーを釣菌分離してGSH−欠損
株(例えば、エシエリヒア・コリC912)を取得
する。次いで、このGSH−欠損株に前記と同
様の処理手段で変異を誘起せしめたのち、8−ハ
イドロキシキノリンを含むDM培地で培養し、生
ずるコロニーを釣菌分離することにより、GSH
−活性及びGSH−活性を有し、かつグルタ
チオンによるGSH−への阻害が解除された菌
体を取得することができる。かくして得られる菌
株の例としては、例えばエシエリヒア・コリ
RC912(微工研条寄第47号)が挙げられる。 上記の如くして取得した本発明の微生物を培養
するに際して用いられる培地としては、炭素源、
窒素源、無機物などを程よく含有するものであれ
ば、合成培地または天然培地のいずれも使用でき
る。炭素源としては、例えばグルコース、シユー
クロース、フラクトース、でん粉、でん粉加水分
解物、糖密などの種々の炭化水素が使用でき、そ
の使用量は0.5〜5.0%程度が好ましい。また窒素
源としては、例えば硫酸アンモニウム、リン酸ア
ンモニウム、炭酸アンモニウム、酢酸アンモニウ
ムなどの各種の無機および有機アンモニウム類、
あるいはペプトン、酵母エキス、コーンスチープ
リカー、カゼイン加水分解物などの窒素性有機物
などが使用でき、その使用量は0.5〜2.0%程度が
好ましい。更に無機物としては、例えばリン酸第
一水素カリウム、リン酸第二水素カリウム、硫酸
マグネシウム、硫酸マンガンなどが使用でき、そ
の使用量は0.005〜0.5%程度が好ましい。 培養は振とう培養あるいは通気かく拌培養など
の好気的条件下に行なうのが好ましい。培養温度
は25〜37℃が好適であり、培養期間は通常16〜40
時間程度で充分である。かくして菌体内に著量の
グルタチオンが蓄積する。 培養終了後、菌体内のグルタチオンを抽出す
る。グルタチオンの抽出は水で加熱抽出すること
によつて容易に実施することができる。抽出液よ
りグルタチオンを単離するには、該抽出液をイオ
ン交換樹脂処理の如き公知の方法で処理すること
によつて行なうことができる。 以下本発明の実施例を示す。 実施例 1 下記第1表に示す菌株をグルコース0.5%、リ
ン酸第一水素カリウム0.3%、リン酸第二水素カ
リウム0.7%、硫酸マグネシウム・7水和物0.01
%、硫酸アンモニウム0.1%の組成の培地(PH
7.0)に接種し、37℃で16時間振とう培養した。
培養終了後、遠心分離により菌体を集め、0.85%
生理食塩水で洗浄後、菌体中のグルタチオンを水
で加熱抽出した。抽出液中のグルタチオン量を定
量し、菌体1g(湿重量)当りのグルタチオン蓄
積量(μmole)を算出した。その結果は下記第1
表の通りであつた。 【表】
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing glutathione, and more specifically, a method for producing glutathione by an extraction method from the cells of a microorganism belonging to the genus Escherichia in which the control mechanism of the glutathione synthase system has been released. Regarding. Glutathione is a tripeptide consisting of L-glutamic acid, L-cysteine and glucine,
It is a substance useful as a treatment for liver diseases, an antidote, etc. It is also a substance useful as a biochemical reagent. Conventionally, methods for producing glutathione using microorganisms include a method of extracting glutathione from yeast cells, and a method of contacting dry yeast with good membrane permeability with a substrate solution containing L-glutamic acid, L-cysteine, and glycine. There are known methods for producing glutathione, and methods for conjugating an ATP regeneration system when producing glutathione by contacting yeast or Escherichia coli cells with a substrate solution. However, when viewed as an industrial production method, these methods do not necessarily produce a satisfactory amount of glutathione. In view of this situation, the present inventors have conducted various studies to find a method for industrially advantageous production of glutathione using microorganisms, and have found that glutathione belongs to the genus Escherichia. The present inventors have discovered that microorganisms that have the activity and whose γ-glutamylcysteine enzyme is no longer inhibited by glutathione accumulate a significant amount of glutathione within their cells, leading to the completion of the present invention. That is, the present invention is a method for producing glutathione, which comprises culturing the above-mentioned microorganism and extracting glutathione from the microorganisms thus obtained. The microorganism used in the present invention belongs to the genus Escherichia and has γ-glutamylcysteine synthase (E.
C.6.3.2.2., hereinafter referred to as GSH-) activity and glutathione synthase (EC6.3.2.3., hereinafter referred to as GSH-) activity, and has glutathione-mediated GSH- Any microorganism that has been released from inhibition can be used, and a typical example of such a microorganism is GSH-
Suitable examples include Escherichia coli which has GSH-activity and GSH-activity and in which the inhibition of GSH- by glutathione has been released. The above bacterial strain can be obtained, for example, as follows. First, GSH-activity and a wild strain of E. coli with GSH-activity (e.g.
A cysteine-requiring strain and a methylglyoxal-resistant strain are obtained by inducing mutations in Escherichia coli B355). Mutations can be induced by conventional mutagenesis treatments, such as N-methyl-
This can be carried out by treatment with a mutagenic agent such as N'-nitro-N-nitrosoguanidine. To obtain a cysteine auxotroph, the resulting strain is subjected to mutagenesis in a minimal medium containing 2×10 -5 M cysteine (e.g., K 2 HPO 4 0.7%, KH 2 PO 4 0.3%,
It can be obtained by culturing in a medium containing 0.1% (NH 4 ) 2 SO 4 and 0.5% glucose (hereinafter referred to as DM medium) and separating the resulting small colonies. On the other hand, a methylglyoxal-resistant strain can be obtained by culturing the strain obtained by the above mutagenesis treatment in a DM medium containing methylglyoxal, and separating the resulting large colonies by fishing. Next, the above-mentioned methylglyoxal-resistant strain is cultured in a minimal medium containing the cysteine-requiring strain obtained above, and colonies that do not form a halo around the colony are isolated to obtain a GSH-deficient strain (e.g., Escherichia coli C912). get. Next, mutations were induced in this GSH-deficient strain using the same treatment methods as described above, followed by culturing it in a DM medium containing 8-hydroxyquinoline, and the resulting colonies were isolated by fishing to induce GSH-deficient strains.
- activity and GSH- activity, and in which the inhibition of GSH- by glutathione has been released. Examples of bacterial strains obtained in this way include, for example, Escherichia coli.
An example is RC912 (Feikoken Jokyo No. 47). The medium used for culturing the microorganism of the present invention obtained as described above includes a carbon source,
Either a synthetic medium or a natural medium can be used as long as it contains a suitable amount of nitrogen sources, inorganic substances, etc. As the carbon source, various hydrocarbons such as glucose, sucrose, fructose, starch, starch hydrolyzate, and molasses can be used, and the amount used is preferably about 0.5 to 5.0%. Examples of nitrogen sources include various inorganic and organic ammoniums such as ammonium sulfate, ammonium phosphate, ammonium carbonate, and ammonium acetate;
Alternatively, nitrogenous organic substances such as peptone, yeast extract, corn steep liquor, and casein hydrolyzate can be used, and the amount used is preferably about 0.5 to 2.0%. Further, as the inorganic substance, for example, potassium hydrogen phosphate, potassium dihydrogen phosphate, magnesium sulfate, manganese sulfate, etc. can be used, and the amount used is preferably about 0.005 to 0.5%. The culture is preferably carried out under aerobic conditions such as shaking culture or aeration agitation culture. The suitable culture temperature is 25-37℃, and the culture period is usually 16-40℃.
About an hour is enough. Thus, a significant amount of glutathione accumulates within the bacterial cells. After culturing, glutathione inside the bacterial cells is extracted. Extraction of glutathione can be easily carried out by heating extraction with water. Glutathione can be isolated from the extract by treating the extract with a known method such as ion exchange resin treatment. Examples of the present invention will be shown below. Example 1 The strains shown in Table 1 below were mixed with 0.5% glucose, 0.3% potassium hydrogen phosphate, 0.7% potassium dihydrogen phosphate, and 0.01% magnesium sulfate heptahydrate.
%, ammonium sulfate 0.1% (PH
7.0) and cultured with shaking at 37°C for 16 hours.
After culturing, collect the bacterial cells by centrifugation and reduce to 0.85%.
After washing with physiological saline, glutathione in the bacterial cells was extracted by heating with water. The amount of glutathione in the extract was quantified, and the amount of glutathione accumulated (μmole) per 1 g (wet weight) of bacterial cells was calculated. The results are shown below.
It was as shown in the table. 【table】

Claims (1)

【特許請求の範囲】 1 エシエリヒア属に属し、γ−グルタミルシス
テイン合成酵素活性及びグルタチオン合成酵素活
性を有しかつグルタチオンによるγ−グルタミル
システイン合成酵素への阻害が解除された微生物
を培養し、かくして得られた菌体よりグルタチオ
ンを抽出することを特徴とするグルタチオンの製
造法。 2 微生物がγ−グルタミルシステイン合成酵素
活性及びグルタチオン合成酵素活性を有し、かつ
グルタチオンによるγ−グルタミルシステイン合
成酵素への阻害が解除されたエシエリヒア・コリ
である特許請求の範囲第1項記載の製造法。
[Scope of Claims] 1. A microorganism belonging to the genus Escherichia that has γ-glutamylcysteine synthetase activity and glutathione synthetase activity and in which inhibition of γ-glutamylcysteine synthetase by glutathione has been released is cultured, A method for producing glutathione, which comprises extracting glutathione from collected bacterial cells. 2. The production according to claim 1, wherein the microorganism is Escherichia coli which has γ-glutamylcysteine synthetase activity and glutathione synthetase activity, and in which inhibition of γ-glutamylcysteine synthetase by glutathione has been released. Law.
JP56120544A 1981-07-30 1981-07-30 Preparation of glutathione Granted JPS5820196A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP56120544A JPS5820196A (en) 1981-07-30 1981-07-30 Preparation of glutathione
EP82304039A EP0071485B1 (en) 1981-07-30 1982-07-30 Novel microorganisms derived from microorganisms of the genus escherichia by mutation and their use in the preparation of glutathione
DE8282304039T DE3279950D1 (en) 1981-07-30 1982-07-30 Novel microorganisms derived from microorganisms of the genus escherichia by mutation and their use in the preparation of glutathione
ES514571A ES514571A0 (en) 1981-07-30 1982-07-30 "A PROCEDURE FOR THE PREPARATION OF GLUTATION".
CA000408484A CA1187432A (en) 1981-07-30 1982-07-30 Microorganism and its use for the preparation of glutathione
ES522801A ES8500328A1 (en) 1981-07-30 1983-05-30 Novel microorganisms derived from microorganisms of the genus Escherichia by mutation and their use in the preparation of glutathione.
US06/670,675 US4596775A (en) 1981-07-30 1984-11-13 Microorganism and its use for the preparation of glutathione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56120544A JPS5820196A (en) 1981-07-30 1981-07-30 Preparation of glutathione

Publications (2)

Publication Number Publication Date
JPS5820196A JPS5820196A (en) 1983-02-05
JPH0147154B2 true JPH0147154B2 (en) 1989-10-12

Family

ID=14788919

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56120544A Granted JPS5820196A (en) 1981-07-30 1981-07-30 Preparation of glutathione

Country Status (1)

Country Link
JP (1) JPS5820196A (en)

Also Published As

Publication number Publication date
JPS5820196A (en) 1983-02-05

Similar Documents

Publication Publication Date Title
US3806416A (en) Creatine amidohydrolase and process for its preparation
US4529697A (en) Process for producing L-glutamic acid by fermentation
FR2463184A1 (en) PROCESS FOR THE PRODUCTION OF L-GLUTAMIC ACID BY FERMENTATION
EP0122794A2 (en) Method for producing L-carnitine
DK143287B (en) PROCEDURE FOR PREPARING ENZYME PREPARATIONS WITH L-ALFA AMINOACYLAMIDASE ACTIVITY AND PROCEDURE FOR PREPARING L-ALFA AMINO ACID AND D-ALFAAMINOSYREAMIDE
CA2143545C (en) Process for producing optically active 4-hydroxy-2-ketoglutaric acids
Tani et al. Production of l-Serine by a Methanol-utilizing Bacterium, Arthrobacter globiformis SK-200
EP0071485B1 (en) Novel microorganisms derived from microorganisms of the genus escherichia by mutation and their use in the preparation of glutathione
JPH0147154B2 (en)
US4357425A (en) Process for producing L-amino acid oxidase
EP0076516B1 (en) Method for fermentative production of l-proline
JP3122990B2 (en) Process for producing O-methyl-L-tyrosine and L-3- (1-naphthyl) alanine
JPH0355116B2 (en)
JPH0147155B2 (en)
JPS582677B2 (en) Production method of L-serine
JPS589672B2 (en) Biseibutsunobayouhouhou
JPS6328596B2 (en)
JP3018471B2 (en) Method for producing L-amino acid
Nelson Jr et al. The synthesis of L-serine by Micrococcus lysodeikticus
JP2899071B2 (en) Method for producing L-α-alanine
JPS5852638B2 (en) Method of racemization of serine
JPS59179094A (en) Production of triazol-deoxyribonucleoside
JPH0322159B2 (en)
JPH0464674B2 (en)
JPS6237949B2 (en)